HOVHANNES TSATURYAN: Open Payments
NPI 1578321089 · ONTARIO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$468 in 20 payments from 12 companies in 2025. Trend: 2023 $0 · 2024 $129 · 2025 $468
Food & beverage: $468
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 5 | $111 |
| Novo Nordisk Inc | 3 | $62 |
| ABBVIE INC. | 2 | $52 |
| Exact Sciences Corporation | 2 | $46 |
| Medtronic, Inc. | 1 | $39 |
| Abbott Laboratories | 1 | $27 |
| Astellas Pharma US Inc | 1 | $26 |
| SHIELD THERAPEUTICS INC | 1 | $26 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $24 |
| Gilead Sciences, Inc. | 1 | $24 |
Products named: MOUNJARO, Cologuard Collection Kit, JARDIANCE, VENASEAL, QULIPTA, KISUNLA, FREESTYLE LIBRE 3, Veozah.
Industry payments across CA — which companies pay providers there.
